Eko Company
.png)
Eko develops FDA approved, AI-powered heart sound and EKG sensors for heart disease monitoring.
Founded Date:
2013-01-01
Last Funding Date:
2020
Employee Number:
11-50
Investors Number:
22
Technology:
Digital Healthcare
Last Funding Type:
Series C
Investor Type:
Late Stage Venture
Headquarters:
San Francisco Bay Area, West Coast, Western US
Total Funding:
95500000
Estimated Revenue:
$1M to $10M
Funding Status:
Late Stage Venture
Industry:
Artificial Intelligence, Health Care, Health Diagnostics, Machine Learning, Medical Device, Software, mHealth